A Critical Examination Of Autoimmunity And Inflammation
Autoinflammatory and autoimmune disorders are characterized by aberrant changes in innate and adaptive immunity that may lead from an initial inflammatory state to an organ specific damage. These disorders possess heterogeneity in terms of affected organs and clinical phenotypes. However, despite the differences in etiology and phenotypic variations, they share genetic associations, treatment responses and clinical manifestations. The mechanisms involved in their initiation and development remain poorly understood, however the existence of some clear similarities between autoimmune and autoinflammatory disorders indicates variable degrees of interaction between immune-related mechanisms. This study sought to critically examine autoimmunity and inflammation.
The study evaluated similarities and specificities of pathway activity changes in twelve autoimmune and autoinflammatory disorders by performing meta-analysis of publicly available gene expression datasets generated from peripheral blood mononuclear cells, using a bioinformatics pipeline that inte- grates Self Organizing Maps and Pathway Signal Flow algorithms along with KEGG pathway topologies. The results reveal that clinically divergent disease groups share common pathway perturbation profiles. Thus, the data suggest that while all of the studied diseases are affected by activation of common inflammatory processes, disease-specific variations in their relative balance are also identified.
Table Of Content
- Table of Content
- 1.1 Background To The Stduy
- 1.2 Statement Of Problem
- 1.3 Purpose Of The Study
2.0 Literature Review
- 2.1 Conceptual Review
- 2.2 The Initiation Of Autoimmunity
- 2.3 The Propagation Of Autoimmune Reactions
- 2.4 The Resolution Of Autoimmunity
- 2.5 Future Prospects
3.0 Material And Methods
- 3.1 Data Sources
- 3.2 Dataset Preprocessing
- 3.3 Pathway Signal Flow Calculation
- 3.4 Spot Based Disease Similarity Assessment
4.0 Results And Discussion
- 4.1 Results
5.0 Summary And Conclusions
- 5.1 Summary
- 5.2 Conclusion
1.1 Background To The Stduy
Epidemiological studies provide increasing evidence for the rise in prevalence of immune- related disorders including autoimmune and allergic diseases in Western countries [1–3]. It is predicted that the incidence of chronic inflammatory disorders, particularly autoimmune diseases, such as type 1 diabetes, Crohn’s disease, rheumatoid arthritis and multiple sclerosis, will grow even more rapidly during the next several decades [1,4,5]. Moreover, chronic inflammation is being recognized as an important trigger and contributor to the development and progression of various other human complex diseases, such as certain cancers, atherosclerosis, strokes and ischemic heart diseases, and even psychiatric disorders (schizophrenia and post-traumatic stress disorder) [6–10].Therefore, understanding the molecular mechanisms underlying the development of inflammatory disorders will have significant impact on public health.
Autoimmune diseases(AI) are characterized by dysfunction of the immune system leading to loss of immune tolerance against self-tissues, by the presence of autoreactive T and B cells, and by a complex pathogenesis of multifactorial etiology, whereas genetics and environmental factors together are responsible for disease onset [11,12].There are more than 80 such condi- tions affecting susceptible human subjects . Autoimmune conditions may be systemic (tar- geting multiple organs and tissues), as is the case of lupus, or tissue specific, as is the case of multiple sclerosis (against myelin) or type 1 diabetes (against pancreatic beta cells). The simul- taneous presence of several autoimmune diseases is observed in some cases, pointing at the possibility of a shared origin and/or mechanisms .
Autoinflammatory diseases (AIF) are a relatively new and expanding group of self-directed inflammatory disorders, clinically described as periodic fever syndromes but also with epi- sodes of acute inexplicable inflammation involving the innate immune system [15,16]. They are characterized by inflammatory episodes at disease-prone sites, in the absence of autoreac- tive T cells and high autoantibody titers [17,18]. Despite the differences in primary players, they share common characteristics with AI diseases, such as self-tissue directed inflammation in the absence of an obvious infectious trigger or injury. While in AIFs the innate immune sys- tem directly causes tissue inflammation, in AIs the innate immune system activates the adap- tive system and this later activates the inflammatory process . The autoinflammatory syndromes include a subset of hereditary conditions characterized by recurrent episodes of fever and self-resolving attacks of systemic inflammation without microbial infection or auto- immunity. There are several AIF associated with genetic mutations affecting the innate immune system, the primary defense system against foreign antigens . Such genetic mutations have been identified affecting genes encoding for the tumor necrosis factor receptor (TNFR1) as is the case for the autosomal dominant TNF receptor associated syndrome (TRAPS)  or the gene encoding for mevalonate kinase (MVK) responsible for the HIDS syndrome. Mutations of the MVK gene are responsible for an increase of mevalonic acid concentrations, elevated levels of IgD in the serum and also an increased secretion of IL-1β [21,22]. Similarly several autoinflammatory syndromes are related with the gene encoding for pyrin . The PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome, a dominantly inherited autoinflammatory condition is associated with mutations in the gene encoding for proline serine threonine phosphatase-interacting protein (PSTPIP1) that inter- acts with pyrin .
Pyrin and PSTPIP1 proteins are associated with the cytoskeleton in mye- loid/monocytes and their interaction contributes to increased IL-1β production, NFkB activation and apoptosis . Finally the connection between pyrin and autoinflammation is observed in the Cryopyrin-Associated Periodic Syndromes (CAPS) in which mutations of genes encoding for the components of the proteins involved in the inflammasome (NLRP3) are implicated [25–27].The phenotypic heterogeneity characteristic of AI and AIF diseases, does not necessarily reflect fundamental genetic or mechanistic differences between these groups. Indeed, while some gene variants and SNPs are specific to a particular disease [11,28], others predispose an individual to the development of multiple disorders, which indicates that shared mutations may affect genes or pathways implicated in the pathogeneses of several dis- eases [29,30]. Moreover, while the mechanisms and causes of development may differ in vari- ous diseases, the downstream effects occurring after the disease onset may be similar. This similarity can potentially underlie responsiveness of different types of diseases to the same type of treatment (e.g. glucocorticoids) [31–33] indicating the presence of shared drug targets.
However, the global picture of molecular mechanisms underlying the similarities and specifici- ties of chronic inflammatory disorders is not completely understood and is addressed in this study, using gene expression data to compare activation patterns of selected pathways in a sub- set of AI and AIF diseases.
Luckily, the advances in high-throughput biological data measurements, explosive growth of data in various public repositories and development of new bioinformatics algorithms for data analysis, already provide an opportunity to address the above mentioned issues from a systems biology viewpoint. Previously, we had developed a bioinformatics pipeline for path- way perturbation based analysis and similarity/specificity assessment of disease groups, and have applied it to a number of lung diseases . The obtained results had confirmed the validity of our methodology, as well as had led us to draw new conclusions on pathological characteristics of lung diseases. In the present work, we have used our approach for global assessment of similarities and specificities of downstream molecular events of chronic inflammation through evaluation of pathway activity changes in autoimmune and autoinflammatory disorders.
1.2 Statement Of Problem
Our goal was to include as many conditions as possible, while in the meantime minimizing heterogeneity of microarray platforms and source tissue used for transcriptome measurement. These criteria left us with four monogenic autoinflammatory, four polygenic autoinflammatory disorders sharing characteristics with autoinflammation and autoimmunity, and four polygenic autoimmune conditions (Table 1). Monogenic autoimmune disorders were not included in our study, as to our knowledge, respective transcriptome data meeting our selec- tion criteria were not available. Even though the apparent heterogeneity of the disorders selected in our study presented a challenge for identification of common mechanisms, the existing similarities and, in particular, the common inflammatory component of these disor- ders, remained intriguing and encouraged us to undertake a comparative gene expression analysis of a large set of existing transcriptome data.
Our study offers a systems biology approach for comparative analysis of gene expression data from cohorts carrying apparent divergent diseases with common immune related manifestations. Despite the limitations discussed below, such studies may contribute to identification of common pathways in autoimmunity and autoinflammation, and have the potential to facilitate development of new experimental strategies for understanding the molecular mechanisms underlying the interplay between those processes.
1.3 Purpose Of The Study
The main aim of this study is to critically examine autoimmunity and inflammation. This study has combined several publicly available datasets for autoimmune and autoinflammatory diseases in an attempt to uncover their common and specific pathobiological features.
5.0 Summary And Conclusions
The data presented in this report support the notion that diseases could be distinguished by pathways of the adaptive or innate immune responses, with the majority of conditions con- necting by variable degrees of interaction between these two systems [94,95]. Our previous study on lung diseases using a similar systems biology approach has resulted in clear separa- tion between cancer and other chronic lung diseases, each group characterized by a specific set of dysregulated pathways . The separation we observed in that study was attributed to a distinct set of pathomechanisms implicated in cancers (cell proliferation, metabolism) and other lung diseases (immune/inflammatory response and fibrotic tissue remodelling) .
Here we have limited our scope to study only immune-system related diseases, and expected to get higher degree of interrelatedness at the level of pathway activity perturbations, compared to the previous study.
Overall, the study offers a systems biology approach addressing the complexity and redundancy of the immune system mechanisms implicated in the inflammatory origin of the patho- genesis of the studied diseases.
Identification of pathways shared between different diseases, has the potential to generate novel hypotheses and elaborate methods to subvert the immune dysfunction by modulating networks through regulation of one gene or miRNAs. Moreover, it may contribute to our understanding of similarities and differences in responses to similar treatment depending on specific patterns of pathway alterations. The selection of pathway level resolution provides a more aggregated level of information, as compared to single gene level analysis.
How To Get The Complete Material For A Critical Examination Of Autoimmunity And Inflammation
The Complete Material Will Be Sent to You in Just 2 Steps
Quick & Simple…
Make Payment (Through Transfer) of ₦3,000 to Any of the Account Below
|Acc No: 0811003731|
|Acc No: 1225513212|
|Acc No: 8143831497|
Or CLICK HERE To Pay With Debit Card
|FOR CLIENTS OUTSIDE NIGERIA|
|CLICK HERE To Purchase Material ($15)|
|FOR GHANIAN CLIENTS|
|Make Payment of 80 GHS to 0553978005 | Douglas Osabutey | MTN MoMo|
Send the Following Details on WhatsApp ( 08143831497) After Payment
- Payment Details
- Email Address
- A Critical Examination Of Autoimmunity And Inflammation
The Complete Material Will Be Sent To Your Email Address After Receiving Your Details
T & C Apply